A set of coumarin-based fluorescent sugar conjugates – ManCous is reported. ManCous are specific for fructose transporter GLUT5 and cover a broad range of the fluorescence spectrum providing essential tools for the evaluation of fructose transport capacity in live cells.
Point-of-care applications rely on biomedical sensors to enable rapid detection with high sensitivity and selectivity. Despite advances in sensor development, there are challenges in cancer diagnostics. Detection of biomarkers, cell receptors, circulating tumor cells, gene identification, and fluorescent tagging are time-consuming due to the sample preparation and response time involved. Here, we present a novel approach to target the enhanced metabolism in breast cancers for rapid detection using fluorescent imaging. Fluorescent analogs of fructose target the fructose-specific transporter GLUT5 in breast cancers and have limited to no response from normal cells. These analogs demonstrate a marked difference in adenocarcinoma and premalignant cells leading to a novel detection approach. The vastly different uptake kinetics of the analogs yields two unique signatures for each cell type. We used normal breast cells MCF10A, adenocarcinoma cells MCF7, and premalignant cells MCF10AneoT, with hepatocellular carcinoma cells HepG2 as the negative control. Our data indicated that MCF10AneoT and MCF7 cells had an observable difference in response to only one of the analogs. The response, observed as fluorescence intensity, leads to a two-point assessment of the cells in any sample. Since the treatment time is 10 min, there is potential for use in rapid on-site high-throughput diagnostics.
3 May 2018 in Journal of Physical Organic Chemistry
Rapid detection of carcinogenesis is the holy grail in timely cancer detection and point-of-care applications. Realization of these applications has been hampered by lack of specificity and/or selectivity of biomarkers and the low concentrations at which the biomarkers are available. A majority of the detection technologies rely on cell-receptor interactions, activation of specific receptors, gene identification and fluorescent tagging. All these techniques are time consuming and often require specialized equipment. Here we present a method to use the enhanced metabolism in breast cancer that relies on fructose for nutrition. Using fluorescent-labeled fructose analogs as reporter probes, we have demonstrated that cancer cells can be optically identified in a very short time due to the efficient internalization of the probe by cancer cells through the fructose-specific transporter. In our trials using breast cancer and normal cells, we were able to show an eight-times higher fluorescence in cancer cells compared to basal uptake in normal within 10 minutes. The cancer cells were distinguishable from normal cells by monitoring the accumulation of the coumarin-induced fluorescence using a conventional microscope and simple image processing.
A general approach to C3 modification of purine scaffold through various types of cross-coupling reactions has been established. Tuning substrate electronics and reaction conditions resulted in the development of highly efficient sp2–sp, sp2–sp2, and sp2–sp3 cross-coupling conditions for modification of 3-deazaadenine to access C3-modified adenine and hypoxanthine scaffolds. The optimized methodologies to access the corresponding 3-deazaadenosine phosphoramidites for solid-phase DNA synthesis have been demonstrated.